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Background: Infusion fluids may be contaminated with different types of particulates that are a potential health
hazard. Particulates larger than microvessels may cause an embolism by mechanical blockage and inflammation;
however, it has been reported that particulates smaller than capillary diameter are relatively safe. Against such a
background, one report showed that polystyrene beads smaller than capillary diameter decreased tissue perfusion
in ischemia–reperfusion injury. This report suggested that polystyrene beads from 1.5- to 6-μm diameter (dia.) may
have unfavorable effects after pretreatment.
Here, we investigated whether injection of polystyrene beads (3- and 6-μm dia.) as an artificial contaminant of
intravenous fluid after lipopolysaccharide (LPS) injection affected mortality and organ damage in mice.
Methods: Mice were divided into four groups and injected: polystyrene beads only, LPS only, polystyrene beads
30 min after LPS, or saline. A survival study, histology, blood examination, and urine examination were performed.
Results: The survival rate after LPS and polystyrene bead (6-μm dia.) injection was significantly lower than that of the
other three groups. In the kidney sections, injured glomeruli were significantly higher with LPS and polystyrene bead
injection than that of the other three groups. LPS and polystyrene bead injection decreased the glomerular filtration
rate and led to renal failure. Inflammatory reactions induced with LPS were not significantly different between with or
without polystyrene beads. Polystyrene beads were found in urine after LPS and polystyrene bead injection.
Conclusions: Injection of polystyrene beads after LPS injection enhanced glomerular structural injury and caused renal
function injury in a mouse sepsis model.
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Infusion fluids may be contaminated with particulates,
bacteria, endotoxins, precipitates, large lipids, and air.
Different types of particulates have been described and
recognized as a potential health hazard [1-3]. Particulates
larger than microvessels may cause an embolism by mech-
anical blockage. In addition, larger particulates activate
platelets and neutrophils and have indirect effects on
vasomotor activity, including effects on the microcircu-
lation, causing thrombi and granuloma formation [4-6];
however, there are no established animal models showing
that larger particulates cause significant systemic functional* Correspondence: harima@med.nagoya-cu.ac.jp
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reproduction in any medium, provided the oror morphological injuries [4,7] but only local injuries such
as the formation of foreign body granulomas in the lungs
and other organs. The reason for the lack of animal models
is unknown, but in previous studies, larger particulates have
been injected into healthy animals. In addition, the injection
of particulates smaller than the inner luminal diameter of
microvessels is relatively safe [8]. Smaller particulates are
rapidly eliminated from the blood stream within the
first 60–90 min after injection. These particulates mainly
accumulate in the liver.
Against such a background, one report showed that
polystyrene beads as an artificial intravenous fluid con-
taminant smaller than the inner luminal diameter of
microvessels decreased microcirculatory tissue perfusion
in ischemia–reperfusion injury [4]. In this report, injection
of polystyrene beads (1.5-, 3-, 4.5-, and 6-μm diameter
(dia.)) did not decrease capillary perfusion, but injection oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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a statistically significant loss of capillary perfusion in
non-ischemic muscle tissue. On the other hand, even the
smallest 1.5-μm diameter polystyrene beads significantly
reduced capillary perfusion from the baseline value in
post-ischemic muscle tissue. This report suggested that
polystyrene beads smaller than 6-μm diameter do not
cause embolisms, but this size of polystyrene bead may
have unfavorable effects after pretreatment.
We therefore hypothesized that smaller particulates that
do not cause embolisms have unfavorable effects on septic
shock animals with the involvement of lipopolysaccharide
(LPS). Here, we used polystyrene beads as an artificial
intravenous fluid contaminant and investigated the effect
of 3- and 6-μm dia. polystyrene bead injection after LPS
injection in mice. First, mortality was investigated and
then organ damage was screened by histology.
Methods
Animal protocols
After institutional ethics approval (conforming to the
guidelines of the Centre for Animal Science, Nagoya
City University Graduate School of Medical Sciences),
male C57 BL6 non-SPF mice (6–7 weeks old, 20–25 g)
obtained from Japan SLC, Inc. (Hamamatsu, Japan) were
used in all experiments and were housed at 22–24°C
under a 12-h light/12-h dark cycle.
Animals were randomized to polystyrene bead injection
(106–109/kg, 3- or 6-μm dia., Polybead Microspheres
3.00 or 6.00 μm; Polysciences, Inc., Warrington, PA, USA.
polystyrene bead-only group; Bead group), LPS injection
(5 mg/kg; Sigma-Aldrich Co., St. Louis, MO: LPS-only
group; LPS group), polystyrene bead injection 30 min after
LPS injection (L + B group), or saline injection (5 ml/kg,
Control group). The size of polystyrene beads used does
not decrease capillary perfusion [4]. The dose of polystyr-
ene beads used was not high compared with another report
[8]. It has been reported that 8.3 × 108/kg polystyrene beads
(4.5-μm dia.) did not cause any macroscopic, clinicopatho-
logical, or histopathological changes in rats [8].
Under inhaled anesthesia with 1.5%–2% isoflurane, the
fur on the right-hand side of the neck of the mouse was
shaved and the skin was disinfected using an iodine solu-
tion. A longitudinal incision of about 15 mm was made in
the neck of the animal, just inside the right front leg. After
careful removal of the connective tissue surrounding
the jugular vein, the indicated drug was slowly (over
10 s) injected through the jugular vein using a 27-gauge
needle, and the skin was sutured [9]. Drugs were diluted
with saline, and the injection volume was adjusted to
about 0.1 ml. During the surgical procedure, the body
temperature of the animals was maintained using an elec-
trical heating pad. After recovery from anesthesia, the ani-
mals were observed and housed individually in cages.Survival study
After injection of the indicated drug, the animals were
housed individually in cages. A status of dead or alive
was recorded every 24 h for 10 days.
Histology
At the indicated time after the injection of the indicated
drug, the animals were euthanized, and the lung, liver,
kidney, and spleen were removed and fixed in 10% buff-
ered formalin. Sections of the lung, liver, and spleen were
processed for hematoxylin and eosin (HE) staining. Sec-
tions of the kidney were processed for HE staining and
periodic acid methenamine silver (PAM) staining. The
histological samples were evaluated in a blinded fashion
by only one pathologist who was not aware of the
randomization of animals. For evaluation of glomeruli
in each kidney section, the severity of the injury was not
taken into account. Glomeruli with thickened and/or
degenerated basement membrane detected by PAM stain-
ing were defined as ‘injured glomeruli’.
Sample collection for blood examination
At the indicated time after injection of the indicated drug,
the animals were euthanized and arterial blood samples
were collected. Serum blood urea nitrogen (BUN) and
creatinine were measured by an automated clinical chem-
istry analyzer (System 7700; Hitachi High-Technologies
Corporation, Tokyo, Japan) with the UV kinetic method
for BUN and enzymatic methods for creatinine. Blood
counts and differential counts of leukocytes were measured
by an automated blood count analyzer (XE-2100; SYSMEX
Co., Kobe, Japan) with the flow cytometry method. Concen-
trations of interleukin (IL)-6 and cystatin C in serum were
measured in duplicates using a commercial kit (Quantikine
ELISA; R&D Systems, Inc., Minneapolis, MN, USA).
Detection of polystyrene beads in glomeruli of kidneys
Dyed polystyrene beads (108/kg, 6-μm dia., Polybead Poly-
styrene Yellow Dyed Microspheres 6.00 μm, Polysciences,
Inc.) were used for ease of identification. Animals were
randomized to dyed polystyrene bead injection (108/kg)
(Dyed Bead group) or dyed polystyrene bead injection
(108/kg) 30 min after LPS injection (5 mg/kg, L +DB
group). At the indicated time after injection of the in-
dicated drug, the animals were euthanized, the kidneys
were removed and embedded in Tissue-Tek O.C.T. Com-
pound (Sakura Finetek Japan Co., Ltd., Tokyo, Japan) in
cryomolds, and then frozen in liquid nitrogen. Twenty mi-
cron, frozen serial sections cut on a standard cryostat were
mounted, fixed in formalin, stained with HE, and rinsed in
distilled water. Because polystyrene beads are soluble in
xylene, slides were analyzed under water-soluble condi-
tions. The histological samples were evaluated in a blinded
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randomization of animals.
Detection of polystyrene beads in urine
Dyed polystyrene beads of 6-μm diameter were used for
ease of identification. After injection of the indicated
drug, the animals were placed individually in metabolism
cages for urine collection. After urine collection, they were
microscopically evaluated for the presence of beads, which
were counted.
Statistical analysis
Data are presented as the mean ± SE. For survival analysis,
the Kaplan–Meier method was used. For multiple com-
parisons, one-way analysis of variance followed by Tukey's
multiple comparison test or two-way analysis of variance
followed by the Bonferroni multiple comparison test
was used. P < 0.05 was considered significant. Analysis was
performed with GraphPad Prism 4 (GraphPad Software,
Inc., La Jolla, CA, USA).
Results
Survival rate
First, polystyrene beads of 3- and 6-μm diameter (108/kg)
were tested. After injection, the animals were followed forA
L + B (3 µm, 108/kg) 
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Figure 1 Survival study. Both 3- and 6-μm diameter polystyrene beads w
(106, 108, or 109/kg) (Bead), LPS injection (5 mg/kg) (LPS), polystyrene bead
(L + B), or saline injection (5 ml/kg) (Control) and treated as described. The
recorded every 24 h for 10 days. n = 10 in each group. Asterisk, significantly
from 109/kg within the L + B groups of 6-μm diameter polystyrene beads. (
(B) Survival curve of study (polystyrene beads 6-μm diameter, 108/kg). (C) S
(D) Survival curve of study (polystyrene beads 6-μm diameter, 109/kg).10 days. In the Bead group, LPS group, and Control group
with polystyrene beads of 3- and 6-μm diameter, no mice
died during the 10 days. In the L + B group with 3-μm
diameter beads, half of the mice died within 3 days,
but the rest of the mice did not die during the 10 days
(Figure 1A). This survival rate of the L + B group (3-μm
dia., 108/kg) was not significantly lower than that of the
Control group. In the L + B group with 6-μm diameter
beads, nine mice died within 4 days, but one mouse did
not die during the 10 days (Figure 1B). This survival rate
of the L + B group (6-μm dia., 108/kg) was significantly
lower than that of the Control group. Next, 106 and 109/kg
of beads (6-μm dia.) were tested. The survival rates of the
L + B groups (6-μm dia., 106 and 109/kg) were significantly
lower than that of the Control group (Figure 1C,D). Com-
pared with the survival rates within the L + B groups of
6-μm dia., 109/kg is significantly lower than 108 and 106/kg.
The survival rates of 108/kg (6-μm dia., L + B group) was
lower than 106/kg (6-μm dia., L + B group), but the differ-
ence was not significant. Beads after LPS injection de-
creased the survival rate in a dose-dependent manner.
Histology
From the survival study, it became clear that polystyrene
beads of 6-μm diameter have significantly harmful effects.B
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D
ere investigated. Mice were randomized to polystyrene bead injection
injection (106, 108, or 109/kg) 30 min after LPS injection (5 mg/kg)
animals were observed in cages, and the status of dead or alive was
different from Control at P < 0.05. Number sign, significantly different
A) Survival curve of study (polystyrene beads 3-μm diameter, 108/kg).
urvival curve of study (polystyrene beads 6-μm diameter, 106/kg).
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were used for the following experiments. To determine
which organ was damaged, the lung, liver, kidney, and
spleen were examined histologically. There was no signifi-
cant difference in the lung sections from the four groups
(data not shown).
In the liver sections (Figure 2, upper and second col-
umn), there were granules of glycogen in the liver cells
around central venous lesions in the Control group
and Bead group. Meanwhile, granules of glycogen inFigure 2 Histology. Mice were randomized to polystyrene bead injection
bead injection (108/kg, 6-μm dia.) 30 min after LPS injection (5 mg/kg) (L +
Forty-eight hours after injection, the liver, kidney, and spleen were remove
eosin (HE) staining. Sections of each kidney tissue were processed for HE st
line is HE staining of liver (low and high magnification), HE stain of kidney, PAM
respectively. Vertical lines are Control, Bead, LPS, and L + B, respectively. Arrows
LM, low magnification; HM, high magnification; Black bar, 100 μm.the liver cells involving the entire liver lobule were
detected in the LPS group and L + B group. In the L + B
group, two fifth of the mice had fewer granules of
glycogen in the liver cells. Hepatic lipidosis around
portal lesions was also found in some of the LPS group
and L + B group. There was no necrosis in any group.
The number of Kupffer cells was not different among
the groups (data not shown). The changes in the liver
might have been toxic reactions to LPS but not to
particles.(108/kg, 6-μm dia.) (Bead), LPS injection (5 mg/kg) (LPS), polystyrene
B), or saline injection (5 ml/kg) (Control) and treated as described.
d. Sections of the liver and spleen were processed for hematoxylin and
aining and periodic acid methenamine silver (PAM) staining. Horizontal
staining of kidney, and HE staining of spleen (low and high magnification),
indicate neutrophils. Control (n= 4), Bead (n= 4), LPS (n= 4), L + B (n= 5).
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there was a very slight effect when treated with polystyr-
ene beads only. The thickness of the glomerular basement
membrane in a small number of glomeruli was slightly
increased by polystyrene beads that were counted as
‘injured glomeruli’. In the LPS group and L + B group,
the basement membrane of some glomeruli was thickened
and/or degenerated, which was defined as ‘injured glom-
eruli’. Slight mesangial proliferation was also detected in
the LPS group and L + B group. No extracapillary prolifer-
ation or sclerosis in glomeruli was detected in any groups.
The percentage of injured glomeruli is presented in
Figure 3A. Injured glomeruli were significantly increased
by treatment with LPS with or without polystyrene beads
and were significantly higher in the L + B group than LPS
group. There was no tubular damage or necrosis in any
group. This means that glomeruli were injured by LPS.
Polystyrene beads had only small effects on glomeruli but
had synergetic effects with LPS injection.
In the spleen sections (Figure 2, fifth and lower column),
infiltration of neutrophils was detected in the red pulp of
the spleen. Neutrophils in the red pulp per unit area were
significantly increased by LPS treatment, but not by
particle treatment (Figure 3B). The percentage of white
pulp area was significantly increased by LPS treatment
(Figure 3C). There was no significant difference between
the LPS group and L + B group in the infiltration of neutro-
phils and percentage of white pulp area. This means that
polystyrene beads did not affect systemic inflammatory
reactions induced by LPS.Biochemical and hematological examinations
From the histological study, it became clear that the kidney
was a key organ. Thus, to evaluate kidney function, serum











































Figure 3 Analysis of histology. In the sections obtained from Figure 2, th
neutrophils into red pulp per unit area, and percentage of white pulp area
L + B (n = 5). Single asterisk, triple asterisks, significantly different from Cont
different between LPS and L + B at P < 0.001. (A) Percentage of injured glo
section of Figure 1 were counted, and the percentages of injured glomeru
area. In spleen sections of Figure 1, neutrophils in red pulp were counted a
spleen. In the spleen sections of Figure 1, areas of white and red were meacreatinine, and cystatin C were significantly increased
only in the L + B group (Figure 4A,B,C). This means that
saline, polystyrene beads only, and LPS only did not cause
acute kidney injury; however, injection of polystyrene
beads 30 min after LPS injection decreased the glomerular
filtration rate and led to renal failure [10,11].
Findings from the histological study showed that
polystyrene beads did not affect systemic inflammatory
reactions induced by LPS. To evaluate the inflammatory
reaction in blood, the blood count, differential count of
leukocytes, and serum IL-6 were measured. White blood
cell count was significantly decreased by treatment with
LPS with or without polystyrene beads, but there was
no difference between the LPS group and L + B group
(Figure 5A). Differential count of leukocytes and serum
IL-6 were significantly increased by treatment with LPS
with or without polystyrene beads, but there was no sig-
nificant difference between the LPS group and L + B
group (Figure 5B,C). Serum IL-6 of LPS group and L + B
group returned to the baseline level 48 h after injection
(data not shown). This means that polystyrene beads
did not affect systemic inflammatory reactions induced
by LPS [12].Examination of dyed polystyrene beads in glomerulus
and urine
We could not detect polystyrene beads by common HE
staining in the kidney. Polystyrene beads are dissolved by
organic solvents, which are common drugs for histology.
We therefore tried frozen section techniques without
organic solvents to investigate the mechanism of glom-
erular injury associated with polystyrene beads and
LPS. In addition, dyed polystyrene beads were injected
instead of normal polystyrene beads to make them easy
to find under a microscope. In both the Dyed BeadLPS L+B
*** ***






















e percentage of injured glomeruli in the kidney, infiltration of
of the spleen were analyzed. Control (n = 4), Bead (n = 4), LPS (n = 4),
rol at P < 0.05, 0.001, respectively. Triple number signs, significantly
meruli in the kidney. Injured and uninjured glomeruli in each kidney
li are presented. (B) Infiltration of neutrophils into red pulp per unit
nd presented as per unit area. (C) Percentage of white pulp area of













































Figure 4 Evaluation of kidney function. Mice were randomized to polystyrene bead injection (108/kg, 6-μm dia.) (Bead), LPS injection
(5 mg/kg) (LPS), polystyrene bead injection (108/kg, 6-μm dia.) 30 min after LPS injection (5 mg/kg) (L + B), or saline injection (5 ml/kg) (Control)
and treated as described. Forty-eight hours after injection, serum was obtained and measured. n = 4 in each group. Double asterisks, triple
asterisks, significantly different from Control at P < 0.01, 0.001, respectively. Single number sign, triple number signs, significantly different between
LPS and L + B at P < 0.05, 0.001, respectively. (A) Serum BUN 48 h after injection. (B) Serum creatinine 48 h after injection. (C) Serum cystatin
C 48 h after injection.
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detected in glomeruli (Figure 6A). Dyed polystyrene
beads in glomeruli were counted but there was no sig-
nificant difference between the Dyed Bead group and
L + DB group (Figure 6B).
Next, dyed polystyrene beads were counted in urine
(Figure 6C). There was a significant difference between
the Dyed Bead group and L +DB group. Few dyed polystyr-
ene beads were found in urine in the Dyed Bead group.
Dyed polystyrene beads were eliminated in urine from 0 to
12 h after injection in the L +DB group. The elimination of
dyed polystyrene beads peaked from 3 to 6 h after injection.
These studies using dyed polystyrene beads revealed that
injected polystyrene beads stuck in the glomeruli in the
Dyed Bead group and L +DB group, whereas polystyrene
beads passed through the injured glomeruli only in the
L + DB group.A B





































Figure 5 Evaluation of inflammatory reaction. Mice were randomiz
injection (5 mg/kg) (LPS), polystyrene bead injection (108/kg, 6-μm di
(5 ml/kg) (Control) and treated as described. Twenty-four or 48 h afte
group. Single asterisk, double asterisks, third asterisks, significantly dif
White blood cell count 48 h after injection. (B) Differential count of
injection.Discussion
Polystyrene bead injection alone had no effect on the
survival rate, kidney function, or inflammatory reaction
but slightly increased the thickness of the glomerular
basement membrane. LPS injection alone also had no
effect on the survival rate or kidney function, but evoked
toxic and inflammatory reactions and injured glomeruli.
Polystyrene bead injection 30 min after LPS injection
had the worst effect on the survival rate; however, the
systemic inflammatory reaction associated with LPS was
the same with or without polystyrene beads. A difference
between with and without polystyrene beads after LPS
injection was found in the kidney. Polystyrene bead injec-
tion after LPS injection severely damaged the glomerulus.
It can be summarized that polystyrene beads damaged the
glomerular basement membrane only slightly but did not
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a.) 30 min after LPS injection (5 mg/kg) (L + B), or saline injection
r injection, serum was obtained and measured. n = 4 in each
ferent from Control at P < 0.05, 0.01, 0.001, respectively. (A)
leukocytes 48 h after injection. (C) Serum IL-6 24 h after
AB
C











































Figure 6 Detection of polystyrene beads in glomeruli of kidneys
and urine. Mice were randomized to dyed polystyrene bead injection
(108/kg, 6-μm dia.) (Dyed Bead) or dyed polystyrene bead injection
(108/kg, 6-μm dia.) 30 min after LPS injection (5 mg/kg) (L + DB) and
treated as described. (A) Three, six, or twelve hours after injection, the
kidney sections were obtained. Dyed Bead (n = 3), L + DB (n = 5).
Picture shows one of the Sections 6 h after injection in L + DB. Dyed
polystyrene beads are found in the glomeruli (arrows). Black bar,
100 μm. (B) In the sections obtained from Figure 6A, dyed polystyrene
beads in the glomeruli were counted and presented per number of
glomeruli. Dyed Bead (n = 3), L + DB (n = 5). (C) Mice were randomized
to Dyed Bead or L + DB and treated as described. Urine 0–3, 3–6, and
6–12 h after injection was collected, and dyed polystyrene beads were
counted and presented per weight of animals. Dyed Bead (n = 5),
L + DB (n = 5). Asterisk, significantly different between Dyed Bead and
L + DB at P < 0.0001. Number sign, significantly different from 3–6 h
after injection of L + DB at P < 0.001.
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accelerated the damage, decreased the glomerular filtra-
tion rate, and led to renal failure.The details of glomerular injury due to LPS and poly-
styrene beads are not clear. It is said that LPS induces
glomerular injury. The renal filtration barrier consists of
fenestrated endothelial cells, the glomerular basement
membrane, and podocytes of epithelial cells. Foot pro-
cesses of podocytes interdigitate with one another and
form a slit diaphragm. Nephrin is a transmembrane protein
that is a key structural component of the slit diaphragm
and is located at the slit diaphragm between adjacent
podocyte foot processes [13]. LPS is known to damage
glomerular nephrin. This damage led to breakdown of the
slit diaphragm and renal filtration barrier and then in-
duced albuminuria in mice [14-17]. In our study, polystyr-
ene beads stuck in the glomerulus were not significantly
different with or without LPS; however, polystyrene beads
passed through the renal filtration barrier injured by LPS.
It is suggested that local mechanical injury due to poly-
styrene beads is one of the causes of glomerular dam-
age. Polystyrene beads may mechanically injure the renal
filtration barrier injured by LPS as they attach and pass
through the barrier. Due to the combination of these two
types of damage, from LPS and polystyrene beads, the
glomerulus might be severely injured. Our results that
polystyrene beads did not affect systemic inflammation re-
actions induced by LPS, larger polystyrene beads of 6-μm
diameter were more harmful than smaller beads of 3-μm
diameter and polystyrene beads of 6-μm diameter de-
creased the survival rate in a dose-dependent manner,
support our hypothesis.
It is not clear whether our model of polystyrene beads
and LPS is relevant to clinical sepsis. There are two
limitations of our study. The first limitation is artificial
intravenous fluid contaminants. In the clinical setting,
many particulates have been found in used in-line IV
filters [18]. The amount was a mean of 550 particulates/
cm2 (8–1,993 particulates/cm2). Particulate size ranged
from 5 to >100 μm with the majority between 5 and
50 μm. Silicon, which originates mainly from storage in
glass ampules, was the most frequently detected element
in the analysis of individual particulates. It has been re-
ported that glass particulates had immunomodulating
effects on endothelial cells and macrophages in vitro
[18]. This study used inhomogeneous glass particulates
(2–20 μm). Glass particulates have an angular shape
and crystalline appearance. Polystyrene beads are different
from the observed particulates. In the experimental setting,
similarly sized glass particulates are not in commercial
production and are therefore unavailable, so, we used
polystyrene beads as an artificial intravenous fluid con-
taminant, 3 and 6 μm in diameter and spherical. The
second limitation is the sepsis animal model. In the clinical
setting, sepsis is caused by the immune response to a
serious infection, most commonly bacteria. In the experi-
mental setting, there are many models of sepsis, such as
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fusion or instillation of exogenous bacteria. The LPS injec-
tion model is simple and has been widely used for sepsis
research. We therefore used LPS injection as a sepsis
animal model.
Two in-line IV filters are currently in widespread use:
0.2-μm filters for crystalline solutions and 1.2-μm filters
for lipid-containing admixtures. Positively charged 0.2-μm
filters are able to retain particles, air, microorganisms, and
endotoxins [1]. In-line IV filters can remove contaminants
from intravenous solutions [19], but may have unwanted
effects, such as clogging and a reduced flow rate, drugs
binding to the filter itself, and so on. Furthermore, in-line
IV filters add cost [19-21]. Some reports have suggested
the benefit of in-line IV filters [1,20,22,23], whereas other
reports have rejected their routine use [3,24-26]. To date,
the routine use of in-line IV filters is not standard. In
addition to these findings, here, we could show new re-
sults; polystyrene beads as artificial intravenous fluid
contaminants that do not cause embolisms have a poten-
tial health hazard in a sepsis animal model. To evaluate
the effect of in-line IV filters, further investigation might
be required for patients with sepsis.
Conclusions
We used polystyrene beads as an artificial intravenous
fluid contaminant and investigated the effect of injecting
polystyrene beads after LPS injection in mice. Damage
to glomeruli associated with polystyrene beads only was
zero or minimal; however, once the glomeruli had been
damaged by LPS, polystyrene beads attached and passed
through the renal filtration barrier, accelerated the damage,
and led to renal failure.
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